{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:30:00Z","timestamp":1761060600388},"reference-count":257,"publisher":"Portland Press Ltd.","issue":"12","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,6,29]]},"abstract":"<jats:p>Endogenous digitalis-like factor(s), originally proposed as a vasoconstrictor natriuretic hormone, was discovered in fetal and neonatal blood accidentally because it cross-reacts with antidigoxin antibodies (ADAs). Early studies using immunoassays with ADA identified the digoxin-like immuno-reactive factor(s) (EDLF) in maternal blood as well, and suggested it originated in the feto\u2013placental unit. Mammalian digoxin-like factors have recently been identified as at least two classes of steroid compounds, plant derived ouabain (O), and several toad derived bufodienolides, most prominent being marinobufagenin (MBG). A synthetic pathway for MBG has been identified in mammalian placental tissue. Elevated maternal and fetal EDLF, O and MBG have been demonstrated in preeclampsia (PE), and inhibition of red cell membrane sodium, potassium ATPase (Na, K ATPase (NKA)) by EDLF is reversed by ADA fragments (ADA-FAB). Accordingly, maternal administration of a commercial ADA-antibody fragment (FAB) was tested in several anecdotal cases of PE, and two, small randomized, prospective, double-blind clinical trials. In the first randomized trial, ADA-FAB was administered post-partum, in the second antepartum. In the post-partum trial, ADA-FAB reduced use of antihypertensive drugs. In the second trial, there was no effect of ADA-FAB on blood pressure, but the fall in maternal creatinine clearance (CrCl) was prevented. In a secondary analysis using the pre-treatment maternal level of circulating Na, K ATPase (NKA) inhibitory activity (NKAI), ADA-FAB reduced the incidence of pulmonary edema and, unexpectedly, that of severe neonatal intraventricular hemorrhage (IVH). The fall in CrCl in patients given placebo was proportional to the circulating level of NKAI. The implications of these findings on the pathophysiology of the clinical manifestations PE are discussed, and a new model of the respective roles of placenta derived anti-angiogenic (AAG) factors (AAGFs) and EDLF is proposed.<\/jats:p>","DOI":"10.1042\/cs20171499","type":"journal-article","created":{"date-parts":[[2018,6,21]],"date-time":"2018-06-21T10:45:39Z","timestamp":1529577939000},"page":"1215-1242","update-policy":"http:\/\/dx.doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Role of endogenous digitalis-like factors in the clinical manifestations of severe preeclampsia: a systematic review"],"prefix":"10.1042","volume":"132","author":[{"given":"Vardaman\u00a0M.","family":"Buckalew","sequence":"first","affiliation":[{"name":"Emeritus Professor of Internal Medicine (Nephrology), Wake Forest University School of Medicine, Winston Salem, NC 27157-1053, U.S.A."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"288","published-online":{"date-parts":[[2018,6,21]]},"reference":[{"key":"2021113011023808900_B1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2015.00049","article-title":"Endogenous digitalis-like factors: an overview of the history","volume":"6","author":"Buckalew","year":"2015","journal-title":"Front. Endocrinol."},{"key":"2021113011023808900_B2","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1016\/S0140-6736(82)92462-X","article-title":"The natriuretic hormone and essential hypertension","volume":"1","author":"de Wardener","year":"1982","journal-title":"Lancet"},{"key":"2021113011023808900_B3","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/00005792-198309000-00004","article-title":"The relation of a circulating sodium transport inhibitor (the natriuretic hormone?) to hypertension","volume":"62","author":"de Wardener","year":"1983","journal-title":"Medicine (Baltimore)"},{"key":"2021113011023808900_B4","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/287743a0","article-title":"Endogenous digitalis-like substance in plasma of volume-expanded dogs","volume":"287","author":"Gruber","year":"1980","journal-title":"Nature"},{"key":"2021113011023808900_B5","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/MNH.0000000000000105","article-title":"Pathogenesis of preeclampsia","volume":"24","author":"Sircar","year":"2015","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"2021113011023808900_B6","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1542\/peds.52.4.561","article-title":"Serum digoxin studies in infants and children","volume":"52","author":"Hayes","year":"1973","journal-title":"Pediatrics"},{"key":"2021113011023808900_B7","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1056\/NEJM197211162872003","article-title":"Serum digoxin concentrations in the human fetus, neonate and infant","volume":"287","author":"Rogers","year":"1972","journal-title":"N. Engl. J. Med."},{"key":"2021113011023808900_B8","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1136\/adc.48.1.55","article-title":"Plasma digoxin levels in infants","volume":"48","author":"O\u2019Malley","year":"1973","journal-title":"Arch. Dis. Child."},{"key":"2021113011023808900_B9","first-page":"261","article-title":"Some factors affecting a commercial kit for radioimmunoassay of digoxin using tritiated digoxin","volume":"15","author":"Boink","year":"1977","journal-title":"J. Clin. Chem. Clin. Biochem."},{"key":"2021113011023808900_B10","first-page":"1802","article-title":"Clinical experiences with the determination of the plasma digoxin level","volume":"117","author":"Jambroes","year":"1973","journal-title":"Ned. Tijdschr. Geneeskd."},{"key":"2021113011023808900_B11","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1210\/jcem-58-4-748","article-title":"Endogenous digoxin-immunoreactive substance in human pregnancies","volume":"58","author":"Graves","year":"1984","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2021113011023808900_B12","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/clinchem\/33.3.420","article-title":"Digoxin radioimmunoassay that does not detect digoxin-like substance in serum of newborns, infants, or patients with renal failure","volume":"33","author":"Witherspoon","year":"1987","journal-title":"Clin. Chem."},{"key":"2021113011023808900_B13","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/01.ftd.0000146875.49597.b4","article-title":"New enzyme-linked immunosorbent digoxin assay on the ADVIA IMS 800i system is virtually free from interference of endogenous digoxin-like immunoreactive factors","volume":"27","author":"Dasgupta","year":"2005","journal-title":"Ther. Drug Monit."},{"key":"2021113011023808900_B14","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1097\/00007691-199103000-00005","article-title":"Highly specific radioimmunoassay for digoxin using a monoclonal antibody selected for lack of interference by digoxin-like immunoreactive substances in cord blood sera","volume":"13","author":"Wahyono","year":"1991","journal-title":"Ther. Drug Monit."},{"key":"2021113011023808900_B15","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1093\/clinchem\/29.11.1972","article-title":"Seven different digoxin immunoassay kits compared with respect to interference by a digoxin-like immunoreactive substance in serum from premature and full-term infants","volume":"29","author":"Pudek","year":"1983","journal-title":"Clin. Chem."},{"key":"2021113011023808900_B16","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1093\/clinchem\/31.11.1806","article-title":"Effect of assay conditions on cross reactivity of digoxin-like immunoreactive substance(s) with radioimmunoassay kits","volume":"31","author":"Pudek","year":"1985","journal-title":"Clin. Chem."},{"key":"2021113011023808900_B17","first-page":"878","article-title":"Endogenous immunoreactive digitalis-like substance in neonatal serum and placental extracts","volume":"65","author":"Beyers","year":"1984","journal-title":"S. Afr. Med. J."},{"key":"2021113011023808900_B18","first-page":"57","article-title":"Determination of digoxin in the blood of pregnant women, fetuses and neonates before and during anti-arrhythmic therapy, using four immunochemical methods","volume":"29","author":"Schlebusch","year":"1991","journal-title":"Eur. J. Clin. Chem. Clin. Biochem."},{"key":"2021113011023808900_B19","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/clinchem\/30.2.337","article-title":"Effect of deproteinization on determination of serum digoxin by fluorescence polarization immunoassay","volume":"30","author":"Scherrmann","year":"1984","journal-title":"Clin. Chem."},{"key":"2021113011023808900_B20","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/clinchem\/32.1.97","article-title":"Specific interaction between antidigoxin antibodies and digoxin-like immunoreactive substances in cord serum","volume":"32","author":"Scherrmann","year":"1986","journal-title":"Clin. Chem."},{"key":"2021113011023808900_B21","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0009-9120(86)80025-X","article-title":"Endogenous digitalis-like immunoreactive substances in cord serum characterized by anti-digitoxin and anti-digoxin antibodies. Effect of modulated incubation conditions","volume":"19","author":"Scherrmann","year":"1986","journal-title":"Clin. Biochem."},{"key":"2021113011023808900_B22","first-page":"1418","article-title":"Digoxin-like substance in term pregnancy, newborns, and renal failure","volume":"27","author":"Witherspoon","year":"1986","journal-title":"J. Nucl. Med."},{"key":"2021113011023808900_B23","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/BF00315410","article-title":"Interference from digoxin-like immunoreactive substance(s) in commercial digoxin kit assay methods","volume":"39","author":"Morris","year":"1990","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"2021113011023808900_B24","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/S0009-9120(85)80023-0","article-title":"Digoxin immunoreactivity in cord and maternal serum and placental extracts. Partial characterization of immunoreactive substances by high-performance liquid chromatography and inhibition of Na+, K+-ATPase","volume":"18","author":"Diamandis","year":"1985","journal-title":"Clin. Biochem."},{"key":"2021113011023808900_B25","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/j.1749-6632.1990.tb34294.x","article-title":"Characterization of digoxin-like materials in human cord serum","volume":"595","author":"Chasalow","year":"1990","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"2021113011023808900_B26","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1177\/000456329202900315","article-title":"The contribution of steroids to digoxin-like immunoreactivity in cord blood","volume":"29","author":"Yun","year":"1992","journal-title":"Ann. Clin. Biochem."},{"key":"2021113011023808900_B27","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1210\/jcem-60-6-1135","article-title":"Protein binding of endogenous digoxin-immunoactive factors in human serum and its variation with clinical condition","volume":"60","author":"Valdes","year":"1985","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2021113011023808900_B28","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1042\/cs0770375","article-title":"Comparison between endogenous digoxin-like immunoreactivity and 86Rb uptake by erythrocytes in extracts of human plasma","volume":"77","author":"Balzan","year":"1989","journal-title":"Clin. Sci. (Lond.)"},{"key":"2021113011023808900_B29","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/clinchem\/33.4.606","article-title":"Digoxin-like immunoreactivity eliminated from serum by centrifugal ultrafiltration before fluorescence polarization immunoassay of digoxin","volume":"33","author":"Christenson","year":"1987","journal-title":"Clin. Chem."},{"key":"2021113011023808900_B30","first-page":"603","article-title":"Endogenous cardiac glycoside-like substances in newborns, adults, pregnant women and patients with hypertension or renal insufficiency","volume":"14","author":"Clerico","year":"1988","journal-title":"Drugs Exp. Clin. Res."},{"key":"2021113011023808900_B31","first-page":"33","article-title":"Endogenous digitalis-like factor in pregnant and non-pregnant women","volume":"32","author":"Clerico","year":"1988","journal-title":"J. Nucl. Med. Allied Sci."},{"key":"2021113011023808900_B32","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/S0029-7844(97)00090-2","article-title":"Digoxin-like immunoreactive substance and sodium-potassium-adenosine triphosphatase inhibition in normal pregnancy: a longitudinal study","volume":"89","author":"Gilson","year":"1997","journal-title":"Obstet. Gynecol."},{"key":"2021113011023808900_B33","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/0002-9378(91)90319-M","article-title":"Concentration of digoxin-like immunoreactive substance in patients with preeclampsia and its relation to severity of pregnancy-induced hypertension","volume":"165","author":"Kaminski","year":"1991","journal-title":"Am. J. Obstet. Gynecol."},{"key":"2021113011023808900_B34","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF03348569","article-title":"Total digoxin-like immunoreactive factor(s) in healthy population, uncomplicated term pregnancies and neonates.","volume":"13","author":"Krivoy","year":"1990","journal-title":"J. Endocrinol. Invest."},{"key":"2021113011023808900_B35","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/S0002-9378(87)80024-8","article-title":"Digoxin-like immunoreactive substance in pregnancy","volume":"157","author":"Gonzalez","year":"1987","journal-title":"Am. J. Obstet. Gynecol."},{"key":"2021113011023808900_B36","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/0002-9378(90)91010-A","article-title":"A longitudinal study of maternal digoxin-like immunoreactive substances in normotensive pregnancy and pregnancy-induced hypertension","volume":"162","author":"Kerkez","year":"1990","journal-title":"Am. J. Obstet. Gynecol."},{"key":"2021113011023808900_B37","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/0002-9378(88)90771-5","article-title":"The influence of gestational age and preeclampsia on the presence and magnitude of serum endogenous digoxin-like immunoreactive substance(s)","volume":"158","author":"Phelps","year":"1988","journal-title":"Am. J. Obstet. Gynecol."},{"key":"2021113011023808900_B38","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1093\/clinchem\/34.5.977","article-title":"Secretion of atrial natriuretic peptide and digoxin-like immunoreactive substance during pregnancy","volume":"34","author":"Shrivastav","year":"1988","journal-title":"Clin. Chem."},{"key":"2021113011023808900_B39","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1677\/joe.0.1650669","article-title":"Radioimmunoassay of plasma ouabain in healthy and pregnant individuals","volume":"165","author":"Vakkuri","year":"2000","journal-title":"J. Endocrinol."},{"key":"2021113011023808900_B40","first-page":"29","article-title":"Digoxin-like immunoreactive factor in twin and pregnancy-associated hypertensive pregnancies","volume":"74","author":"Jakobi","year":"1989","journal-title":"Obstet. Gynecol."},{"key":"2021113011023808900_B41","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1042\/cs0770189","article-title":"Serum digoxin-like substances in pregnancy-induced hypertension","volume":"77","author":"Poston","year":"1989","journal-title":"Clin. Sci. (Lond.)"},{"key":"2021113011023808900_B42","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/j.1651-2227.1989.tb11093.x","article-title":"Endogenous digoxin-like factor in neonates: effect of age and relation to serum bilirubin levels","volume":"78","author":"Wolach","year":"1989","journal-title":"Acta Paediatr. Scand."},{"key":"2021113011023808900_B43","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1159\/000068929","article-title":"Digoxin-like immunoreactive substance in nonoliguric hyperkalemia of the premature infant","volume":"83","author":"Mildenberger","year":"2003","journal-title":"Biol. Neonate"},{"key":"2021113011023808900_B44","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1097\/00007691-199111000-00010","article-title":"Interference of digoxin-like immunoreactive substances with TDx digoxin II assay in different patients","volume":"13","author":"Avendano","year":"1991","journal-title":"Ther. Drug Monit."},{"key":"2021113011023808900_B45","first-page":"164","article-title":"Endogenous digitalis-like factors: their possible pathophysiological implications with particular regard to the perinatal period","volume":"10","author":"Biver","year":"1990","journal-title":"Child Nephrol. Urol."},{"key":"2021113011023808900_B46","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/S0009-9120(96)00100-2","article-title":"Comparison of four digoxin immunoassays with respect to interference from digoxin-like immunoreactive factors","volume":"29","author":"Datta","year":"1996","journal-title":"Clin. Biochem."},{"key":"2021113011023808900_B47","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1097\/00007691-200304000-00015","article-title":"Digitalis-like immunoreactive substances in maternal and umbilical cord plasma: a comparative sensitivity study of fluorescence polarization immunoassay and microparticle enzyme immunoassay","volume":"25","author":"Ijiri","year":"2003","journal-title":"Ther. Drug Monit."},{"key":"2021113011023808900_B48","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1159\/000457670","article-title":"Endogenous digoxin-like substance(s) associated with uneventful and high-risk pregnancies","volume":"11","author":"Koren","year":"1988","journal-title":"Dev. Pharmacol. Ther."},{"key":"2021113011023808900_B49","first-page":"251","article-title":"Endogenous digoxin-like immunoreactivity during pregnancy and at birth","volume":"35","author":"Lupoglazoff","year":"1993","journal-title":"Br. J. Clin. Pharmacol."},{"key":"2021113011023808900_B50","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1042\/cs0730291","article-title":"Evidence for an inhibitor of leucocyte sodium transport in the serum of neonates","volume":"73","author":"Morris","year":"1987","journal-title":"Clin. Sci. (Lond.)"},{"key":"2021113011023808900_B51","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0028-2243(90)90049-7","article-title":"Maternal and fetal digoxin-like immunoreactive factor in elective cesarean sections and spontaneous vaginal delivery","volume":"36","author":"Zimmer","year":"1990","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"2021113011023808900_B52","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1203\/00006450-198411000-00008","article-title":"Perinatal changes in a digoxin-like immunoreactive substance","volume":"18","author":"Seccombe","year":"1984","journal-title":"Pediatr. Res."},{"key":"2021113011023808900_B53","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/0002-9378(88)90555-8","article-title":"Atrial natriuretic factor, digoxin-like immunoreactive substance, norepinephrine, epinephrine, and plasma renin activity in human fetuses and their alteration by fetal disease","volume":"159","author":"Weiner","year":"1988","journal-title":"Am. J. Obstet. Gynecol."},{"key":"2021113011023808900_B54","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/S0022-3476(83)80031-6","article-title":"Endogenous substance in newborn infants causing false positive digoxin measurements","volume":"102","author":"Valdes","year":"1983","journal-title":"J. Pediatr."},{"key":"2021113011023808900_B55","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1203\/00006450-198601000-00007","article-title":"Digoxin- and digitoxin-like immunoreactive substances in amniotic fluid, cord blood, and serum of neonates","volume":"20","author":"Ebara","year":"1986","journal-title":"Pediatr. Res."},{"key":"2021113011023808900_B56","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1046\/j.1523-1755.1998.00217.x","article-title":"Temporal relationships between hormonal and hemodynamic changes in early human pregnancy","volume":"54","author":"Chapman","year":"1998","journal-title":"Kidney Int."},{"key":"2021113011023808900_B57","doi-asserted-by":"publisher","first-page":"e14098","DOI":"10.5812\/ijem.14098","article-title":"Hormones and hemodynamics in pregnancy","volume":"12","author":"Tkachenko","year":"2014","journal-title":"Int. J. Endocrinol. Metab."},{"key":"2021113011023808900_B58","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1177\/1933719111424441","article-title":"Increasing evidence for and regulation of a human placental endogenous digitalis-like factor","volume":"19","author":"Ma","year":"2012","journal-title":"Reprod. Sci."},{"key":"2021113011023808900_B59","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1097\/HJH.0b013e328333226c","article-title":"Interaction of Digibind with endogenous cardiotonic steroids from preeclamptic placentae","volume":"28","author":"Fedorova","year":"2010","journal-title":"J. Hypertens."},{"key":"2021113011023808900_B60","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/j.1440-1681.1993.tb01747.x","article-title":"Release of a substance from the human placenta having digoxin-like immunoreactivity","volume":"20","author":"DiGrande","year":"1993","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"2021113011023808900_B61","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1161\/CIRCGENETICS.115.001217","article-title":"Synthesis of an endogenous steroidal Na pump inhibitor marinobufagenin, implicated in human cardiovascular diseases, is initiated by CYP27A1 via bile acid pathway","volume":"8","author":"Fedorova","year":"2015","journal-title":"Circ. Cardiovasc. Genet."},{"key":"2021113011023808900_B62","first-page":"197","article-title":"Comparison between umbilical artery and vein endogenous digoxin-like immuno-active factor levels in normal and pre-eclamptic patients","volume":"79","author":"Schabort","year":"1991","journal-title":"S. Afr. Med. J."},{"key":"2021113011023808900_B63","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1042\/cs0750577","article-title":"A comparison of endogenous digoxin-like immunoreactivity and sodium transport inhibitory activity in umbilical arterial and venous serum","volume":"75","author":"Morris","year":"1988","journal-title":"Clin. Sci. (Lond.)"},{"key":"2021113011023808900_B64","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/S0022-3476(86)81061-7","article-title":"Digoxin-like immunoreactive substances in urine and serum from preterm and term infants: relationship to renal excretion of sodium","volume":"108","author":"Ebara","year":"1986","journal-title":"J. Pediatr."},{"key":"2021113011023808900_B65","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/clpt.1984.254","article-title":"Significance of the endogenous digoxin-like substance in infants and mothers","volume":"36","author":"Koren","year":"1984","journal-title":"Clin. Pharmacol. Ther."},{"key":"2021113011023808900_B66","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/S0002-9378(87)80174-6","article-title":"Digoxin-like immunoreactive substance in fetuses with and without cardiac pathology","volume":"157","author":"Weiner","year":"1987","journal-title":"Am. J. Obstet. Gynecol."},{"key":"2021113011023808900_B67","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/BF02343220","article-title":"Digoxin-like immunoreactive substance in serum of preterm and full-term neonates","volume":"146","author":"Bertrand","year":"1987","journal-title":"Eur. J. Pediatr."},{"key":"2021113011023808900_B68","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/clinchem\/35.1.192","article-title":"Total digoxin-like immunoreactive factor(s), total bilirubin concentration, and birth weight in neonates.","volume":"35","author":"Krivoy","year":"1989","journal-title":"Clin. Chem."},{"key":"2021113011023808900_B69","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1159\/000243114","article-title":"A study into the nature and organ source of digoxin-like immunoreactive substance(s) in the perinatal period","volume":"56","author":"Seccombe","year":"1989","journal-title":"Biol. Neonate"},{"key":"2021113011023808900_B70","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1159\/000243335","article-title":"Existence of a digitalis-like compound in the human fetus","volume":"59","author":"Guedeney","year":"1991","journal-title":"Biol. Neonate"},{"key":"2021113011023808900_B71","first-page":"758","article-title":"Interpretation of elevated postmortem serum concentrations of digoxin in infants and children","volume":"113","author":"Koren","year":"1989","journal-title":"Arch. Pathol. Lab. Med."},{"key":"2021113011023808900_B72","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/S0024-3205(97)00020-9","article-title":"Further evidence for an endogenous digitalis-like compound in newborn and adult plasma detected by anti-ouabain antiserum","volume":"60","author":"Balzan","year":"1997","journal-title":"Life Sci."},{"key":"2021113011023808900_B73","first-page":"38","article-title":"Antidigoxin antibodies neutralize the effect of newborn endogenous digitalis-like factor on erythrocyte 86Rb uptake","volume":"35","author":"Balzan","year":"1991","journal-title":"J. Nucl. Biol. Med."},{"key":"2021113011023808900_B74","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1016\/S0024-3205(00)00779-7","article-title":"Selective inhibition of human erythrocyte Na+\/K+ ATPase by cardiac glycosides and by a mammalian digitalis like factor","volume":"67","author":"Balzan","year":"2000","journal-title":"Life Sci."},{"key":"2021113011023808900_B75","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S0009-9120(86)80048-0","article-title":"Correlation between endogenous digoxin-like immunoreactivity and 3H-ouabain displacement on erythrocyte membranes in extracts of human plasma","volume":"19","author":"Balzan","year":"1986","journal-title":"Clin. Biochem."},{"key":"2021113011023808900_B76","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1111\/j.1749-6632.1997.tb52332.x","article-title":"Functional characterization of an endogenous digitalis-like factor in human newborn plasma","volume":"834","author":"Crambert","year":"1997","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"2021113011023808900_B77","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S0140-6736(96)02257-X","article-title":"An inhibitor of the sodium pump obtained from human placenta","volume":"348","author":"Hilton","year":"1996","journal-title":"Lancet"},{"key":"2021113011023808900_B78","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1177\/1933719110385133","article-title":"Digibind reverses inhibition of cellular rb+ uptake caused by endogenous sodium pump inhibitors present in serum and placenta of women with preeclampsia","volume":"18","author":"Hopoate-Sitake","year":"2011","journal-title":"Reprod. Sci."},{"key":"2021113011023808900_B79","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1124\/pr.108.000711","article-title":"Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets","volume":"61","author":"Bagrov","year":"2009","journal-title":"Pharmacol. Rev."},{"key":"2021113011023808900_B80","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3389\/fendo.2014.00199","article-title":"Natriuretic hormones, endogenous ouabain, and related sodium transport inhibitors","volume":"5","author":"Hamlyn","year":"2014","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"2021113011023808900_B81","doi-asserted-by":"publisher","first-page":"6259","DOI":"10.1073\/pnas.88.14.6259","article-title":"Identification and characterization of a ouabain-like compound from human plasma","volume":"88","author":"Hamlyn","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021113011023808900_B82","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1161\/01.HYP.17.6.930","article-title":"Mass spectral characterization of an endogenous digitalislike factor from human plasma","volume":"17","author":"Mathews","year":"1991","journal-title":"Hypertension"},{"key":"2021113011023808900_B83","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1161\/01.HYP.17.6.936","article-title":"Development of an immunoassay for endogenous digitalislike factor","volume":"17","author":"Harris","year":"1991","journal-title":"Hypertension"},{"key":"2021113011023808900_B84","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1111\/j.1749-6632.2003.tb07283.x","article-title":"11-hydroxylation in the biosynthesis of endogenous ouabain: multiple implications","volume":"986","author":"Hamlyn","year":"2003","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"2021113011023808900_B85","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1210\/endo.135.2.8033829","article-title":"Ouabain is secreted by bovine adrenocortical cells","volume":"135","author":"Laredo","year":"1994","journal-title":"Endocrinology"},{"key":"2021113011023808900_B86","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1161\/01.HYP.29.1.401","article-title":"Angiotensin II stimulates secretion of endogenous ouabain from bovine adrenocortical cells via angiotensin type 2 receptors","volume":"29","author":"Laredo","year":"1997","journal-title":"Hypertension"},{"key":"2021113011023808900_B87","first-page":"E413","article-title":"Ouabain is secreted by the adrenal gland in awake dogs","volume":"264","author":"Boulanger","year":"1993","journal-title":"Am. J. Physiol."},{"key":"2021113011023808900_B88","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1161\/HYPERTENSIONAHA.116.06599","article-title":"Endogenous ouabain: recent advances and controversies","volume":"68","author":"Hamlyn","year":"2016","journal-title":"Hypertension"},{"key":"2021113011023808900_B89","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1161\/01.HYP.30.4.886","article-title":"Ouabain-like factor quantification in mammalian tissues and plasma: comparison of two independent assays","volume":"30","author":"Ferrandi","year":"1997","journal-title":"Hypertension"},{"key":"2021113011023808900_B90","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1159\/000075066","article-title":"Elevated blood levels of endogenous ouabain-like factor in preterm versus mature newborns at birth","volume":"85","author":"Gooz","year":"2004","journal-title":"Biol. Neonate"},{"key":"2021113011023808900_B91","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/HJH.0b013e32831cf2c6","article-title":"Endogenous ouabain in cardiovascular function and disease","volume":"27","author":"Manunta","year":"2009","journal-title":"J. Hypertens."},{"key":"2021113011023808900_B92","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1161\/HYPERTENSIONAHA.114.03919","article-title":"Endogenous ouabain is not ouabain","volume":"64","author":"Lewis","year":"2014","journal-title":"Hypertension"},{"key":"2021113011023808900_B93","doi-asserted-by":"publisher","first-page":"C3","DOI":"10.1152\/ajpcell.00196.2017","article-title":"The pump, the exchanger, and the holy spirit: origins and 40-year evolution of ideas about the ouabain-Na(+) pump endocrine system","volume":"314","author":"Blaustein","year":"2018","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"2021113011023808900_B94","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0303-7207(96)03964-0","article-title":"Bovine adrenocortical cells in culture synthesize an ouabain-like compound","volume":"126","author":"Perrin","year":"1997","journal-title":"Mol. Cell. Endocrinol."},{"key":"2021113011023808900_B95","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1016\/j.lfs.2007.03.013","article-title":"The digitalis-like steroid hormones: New mechanisms of action and biological significance","volume":"80","author":"Nesher","year":"2007","journal-title":"Life Sci."},{"key":"2021113011023808900_B96","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1126\/science.6245447","article-title":"Widespread occurrence in frogs and toads of skin compounds interacting with the ouabain site of Na+, K+-ATPase","volume":"208","author":"Flier","year":"1980","journal-title":"Science"},{"key":"2021113011023808900_B97","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.cca.2013.02.028","article-title":"Analytical aspects of marinobufagenin","volume":"421","author":"Lenaerts","year":"2013","journal-title":"Clin. Chim. Acta"},{"key":"2021113011023808900_B98","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1097\/00004872-199816121-00015","article-title":"Effects of two putative endogenous digitalis-like factors, marinobufagenin and ouabain, on the Na+, K+-pump in human mesenteric arteries","volume":"16","author":"Bagrov","year":"1998","journal-title":"J. Hypertens."},{"key":"2021113011023808900_B99","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1161\/01.HYP.26.5.781","article-title":"Endogenous marinobufagenin-like immunoreactive factor and Na+, K+ ATPase inhibition during voluntary hypoventilation","volume":"26","author":"Bagrov","year":"1995","journal-title":"Hypertension"},{"key":"2021113011023808900_B100","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1161\/01.HYP.31.5.1097","article-title":"Characterization of a urinary bufodienolide Na+,K+-ATPase inhibitor in patients after acute myocardial infarction","volume":"31","author":"Bagrov","year":"1998","journal-title":"Hypertension"},{"key":"2021113011023808900_B101","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1097\/HJH.0b013e328312c86a","article-title":"Monoclonal antibody to an endogenous bufadienolide, marinobufagenin, reverses preeclampsia-induced Na\/K-ATPase inhibition and lowers blood pressure in NaCl-sensitive hypertension","volume":"26","author":"Fedorova","year":"2008","journal-title":"J. Hypertens."},{"key":"2021113011023808900_B102","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1097\/HJH.0b013e32834436a7","article-title":"In preeclampsia endogenous cardiotonic steroids induce vascular fibrosis and impair relaxation of umbilical arteries","volume":"29","author":"Nikitina","year":"2011","journal-title":"J. Hypertens."},{"key":"2021113011023808900_B103","first-page":"19","article-title":"Endogenous Na\/K-ATPase inhibitors in patients with preeclampsia","volume":"52","author":"Averina","year":"2006","journal-title":"Cell Mol. Biol. (Noisy-le-grand)"},{"key":"2021113011023808900_B104","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1177\/1933719112447124","article-title":"DigiFab interacts with endogenous cardiotonic steroids and reverses preeclampsia-induced Na\/K-ATPase inhibition","volume":"19","author":"Ishkaraeva-Yakovleva","year":"2012","journal-title":"Reprod. Sci."},{"key":"2021113011023808900_B105","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1097\/00004872-199917080-00018","article-title":"Circulating bufodienolide and cardenolide sodium pump inhibitors in preeclampsia","volume":"17","author":"Lopatin","year":"1999","journal-title":"J. Hypertens."},{"key":"2021113011023808900_B106","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1681\/ASN.2014020130","article-title":"Reduction in maternal circulating ouabain impairs offspring growth and kidney development","volume":"26","author":"Dvela-Levitt","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"2021113011023808900_B107","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/0024-3205(95)02104-Q","article-title":"Evidence for an endogenous ouabain-like immunoreactive factor in human newborn plasma coeluted with ouabain on HPLC","volume":"57","author":"Di Bartolo","year":"1995","journal-title":"Life Sci."},{"key":"2021113011023808900_B108","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1055\/s-0031-1272965","article-title":"Marinobufagenin levels in preeclamptic patients: a preliminary report","volume":"28","author":"Agunanne","year":"2011","journal-title":"Am. J. Perinatol."},{"key":"2021113011023808900_B109","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1038\/ajh.2010.195","article-title":"The ouabain-binding site of the [alpha]2 isoform of Na,K-ATPase plays a role in blood pressure regulation during pregnancy","volume":"23","author":"Oshiro","year":"2010","journal-title":"Am. J. Hypertens."},{"key":"2021113011023808900_B110","doi-asserted-by":"publisher","first-page":"H1317","DOI":"10.1152\/ajpheart.00532.2011","article-title":"Normal pregnancy: mechanisms underlying the paradox of a ouabain-resistant state with elevated endogenous ouabain, suppressed arterial sodium calcium exchange, and low blood pressure","volume":"302","author":"Jacobs","year":"2012","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"2021113011023808900_B111","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms1043","article-title":"Ouabain protects against adverse developmental programming of the kidney","volume":"1","author":"Li","year":"2010","journal-title":"Nat. Commun."},{"key":"2021113011023808900_B112","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22050729","article-title":"On the many actions of ouabain: pro-cystogenic effects in autosomal dominant polycystic kidney disease","volume":"22","author":"Venugopal","year":"2017","journal-title":"Molecules"},{"key":"2021113011023808900_B113","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1002\/iub.1229","article-title":"Regulation of renal function and structure by the signaling Na\/K-ATPase","volume":"65","author":"Xie","year":"2013","journal-title":"IUBMB Life"},{"key":"2021113011023808900_B114","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ajog.2005.07.049","article-title":"Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia","volume":"195","author":"Ness","year":"2006","journal-title":"Am. J. Obstet. Gynecol."},{"key":"2021113011023808900_B115","doi-asserted-by":"publisher","first-page":"C165","DOI":"10.1152\/ajpcell.1977.232.5.C165","article-title":"Sodium ions, calcium ions, blood pressure regulation, and hypertension: a reassessment and a hypothesis","volume":"232","author":"Blaustein","year":"1977","journal-title":"Am. J. Physiol."},{"key":"2021113011023808900_B116","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1146\/annurev.ph.46.030184.002015","article-title":"Natriuretic hormone","volume":"46","author":"Buckalew","year":"1984","journal-title":"Annu. Rev. Physiol."},{"key":"2021113011023808900_B117","first-page":"2800","article-title":"Endogenous digoxin-immunoactive factor in human subjects","volume":"44","author":"Valdes","year":"1985","journal-title":"Fed. Proc."},{"key":"2021113011023808900_B118","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/0002-9378(89)90539-5","article-title":"Erythrocyte cation metabolism in preeclampsia","volume":"161","author":"Sowers","year":"1989","journal-title":"Am. J. Obstet. Gynecol."},{"key":"2021113011023808900_B119","first-page":"229","article-title":"Endogenous digoxin immunoactivity is elevated in hypertensive pregnancy","volume":"192","author":"Valdes","year":"1985","journal-title":"Prog. Clin. Biol. Res."},{"key":"2021113011023808900_B120","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0002-9378(84)80114-3","article-title":"A digoxin-like immunoreactive substance in preeclampsia","volume":"150","author":"Gusdon","year":"1984","journal-title":"Am. J. Obstet. Gynecol."},{"key":"2021113011023808900_B121","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1210\/jcem-59-6-1070","article-title":"An endogenous ouabain-like factor associated with hypertensive pregnant women","volume":"59","author":"Graves","year":"1984","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2021113011023808900_B122","first-page":"883","article-title":"The possible role of endogenous digitalis-like substance in the causation of pre-eclampsia","volume":"65","author":"Beyers","year":"1984","journal-title":"S. Afr. Med. J."},{"key":"2021113011023808900_B123","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/0895-7061(94)00167-A","article-title":"Digitalis-like factor and digoxin-like immunoreactive factor in diabetic women with preeclampsia, transient hypertension of pregnancy, and normotensive pregnancy","volume":"8","author":"Graves","year":"1995","journal-title":"Am. J. Hypertens."},{"key":"2021113011023808900_B124","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/0020-7292(93)90320-V","article-title":"Endogenous digoxin-immunoreactive substance in normal and preeclamptic pregnancies","volume":"43","author":"Logoglu","year":"1993","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"2021113011023808900_B125","first-page":"535","article-title":"Immunoreactive digitalis-like substance in pre-eclampsia","volume":"70","author":"Odendaal","year":"1986","journal-title":"S. Afr. Med. J."},{"key":"2021113011023808900_B126","first-page":"150","article-title":"Markers of sodium and volume homeostasis in pregnancy-induced hypertension","volume":"74","author":"Seely","year":"1992","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2021113011023808900_B127","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/S0022-3476(87)80309-8","article-title":"Effect of age and serum creatinine on endogenous digoxin-like substances in infants and children","volume":"110","author":"Phelps","year":"1987","journal-title":"J. Pediatr."},{"key":"2021113011023808900_B128","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.2741\/2245","article-title":"Sodium regulation, sodium pump function and sodium pump inhibitors in uncomplicated pregnancy and preeclampsia","volume":"12","author":"Graves","year":"2007","journal-title":"Front. Biosci."},{"key":"2021113011023808900_B129","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/jp.2008.223","article-title":"Erythrocyte sodium\/potassium ATPase activity in severe preeclampsia","volume":"29","author":"Adair","year":"2009","journal-title":"J. Perinatol."},{"key":"2021113011023808900_B130","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1159\/000047058","article-title":"Preeclampsia and Na,K-ATPase activity of red blood cell ghosts from neonatal and maternal blood","volume":"79","author":"Carreiras","year":"2001","journal-title":"Biol. Neonate"},{"key":"2021113011023808900_B131","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/0002-9378(77)90314-3","article-title":"Na\/K- and Mg-ATPase activity in the placenta and in maternal and cord erythrocytes of pre-eclamptic patients","volume":"127","author":"Kuhnert","year":"1977","journal-title":"Am. J. Obstet. Gynecol."},{"key":"2021113011023808900_B132","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-2362.1989.tb00202.x","article-title":"High plasma levels of a ouabain-like factor in normal pregnancy and in pre-eclampsia","volume":"19","author":"Delva","year":"1989","journal-title":"Eur. J. Clin. Invest."},{"key":"2021113011023808900_B133","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1042\/cs0740307","article-title":"A ouabain-displacing factor in normal pregnancy, pregnancy-induced hypertension and pre-eclampsia","volume":"74","author":"Gregoire","year":"1988","journal-title":"Clin. Sci. (Lond.)"},{"key":"2021113011023808900_B134","first-page":"281","article-title":"Partially purified endogenous digitalis-llike factor(s) in cord blood: biological activity and effect of digoxin-binding antibodies","volume":"2","author":"Ghione","year":"1992","journal-title":"Eur. J. Internal Med."},{"key":"2021113011023808900_B135","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1124\/jpet.104.065250","article-title":"Characterization of the neutralizing activity of digoxin-specific Fab toward ouabain-like steroids","volume":"310","author":"Pullen","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"2021113011023808900_B136","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1159\/000415391","article-title":"Endogenous digoxin-like immunoreactivity in urine of preterm infants with late hyponatremia","volume":"67","author":"Kovacs","year":"1988","journal-title":"Contrib. Nephrol."},{"key":"2021113011023808900_B137","doi-asserted-by":"publisher","first-page":"e655","DOI":"10.1542\/peds.2008-3415","article-title":"Impact of changes in serum sodium levels on 2-year neurologic outcomes for very preterm neonates","volume":"124","author":"Baraton","year":"2009","journal-title":"Pediatrics"},{"key":"2021113011023808900_B138","doi-asserted-by":"publisher","first-page":"328.e1","DOI":"10.1016\/j.ajog.2013.11.011","article-title":"Association of cord blood digitalis-like factor and necrotizing enterocolitis","volume":"210","author":"Graves","year":"2014","journal-title":"Am. J. Obstet. Gynecol."},{"key":"2021113011023808900_B139","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1056\/NEJM198802253180815","article-title":"Antidigoxin antibodies in eclampsia","volume":"318","author":"Goodlin","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"2021113011023808900_B140","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1159\/000169054","article-title":"Elevated endoxin-like factor complicating a multifetal second trimester pregnancy: treatment with digoxin-binding immunoglobulin","volume":"16","author":"Adair","year":"1996","journal-title":"Am. J. Nephrol."},{"key":"2021113011023808900_B141","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/jp.2008.181","article-title":"Repeated dosing of digoxin-fragmented antibody in preterm eclampsia","volume":"29","author":"Adair","year":"2009","journal-title":"J. Perinatol."},{"key":"2021113011023808900_B142","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1055\/s-0030-1249762","article-title":"Digoxin immune fab treatment for severe preeclampsia","volume":"27","author":"Adair","year":"2010","journal-title":"Am. J. Perinatol."},{"key":"2021113011023808900_B143","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/jp.2008.224","article-title":"The hemodynamic effects of intravenous digoxin-binding fab immunoglobulin in severe preeclampsia: a double-blind, randomized, clinical trial","volume":"29","author":"Adair","year":"2009","journal-title":"J. Perinatol."},{"key":"2021113011023808900_B144","doi-asserted-by":"publisher","first-page":"119.e1","DOI":"10.1016\/j.ajog.2013.04.010","article-title":"Digoxin antibody fragment, antigen binding (Fab), treatment of preeclampsia in women with endogenous digitalis-like factor: a secondary analysis of the DEEP Trial","volume":"209","author":"Lam","year":"2013","journal-title":"Am. J. Obstet. Gynecol."},{"key":"2021113011023808900_B145","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3109\/10641955.2013.784788","article-title":"Clinical characterization and outcomes of preeclampsia with normal angiogenic profile","volume":"32","author":"Rana","year":"2013","journal-title":"Hypertens. Pregnancy"},{"key":"2021113011023808900_B146","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.jim.2008.05.005","article-title":"Comparison of non-digitalis binding properties of digoxin-specific Fabs using direct binding methods","volume":"336","author":"Pullen","year":"2008","journal-title":"J. Immunol. Methods"},{"key":"2021113011023808900_B147","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1161\/01.HYP.19.6.721","article-title":"Rat adrenal cortex is a source of a circulating ouabainlike compound","volume":"19","author":"Ludens","year":"1992","journal-title":"Hypertension"},{"key":"2021113011023808900_B148","doi-asserted-by":"publisher","first-page":"6079","DOI":"10.1113\/JP272419","article-title":"Pivotal role of alpha-2 Na+ pumps and their high affinity ouabain binding site in cardiovascular health and disease","volume":"594","author":"Blaustein","year":"2016","journal-title":"J. Physiol."},{"key":"2021113011023808900_B149","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.2741\/1701","article-title":"Endogenous digitalis-like factors. A historical overview","volume":"10","author":"Buckalew","year":"2005","journal-title":"Front. Biosci."},{"key":"2021113011023808900_B150","first-page":"51","article-title":"Salt sensitivity, endogenous ouabain and hypertension","volume":"22","author":"Hamlyn","year":"2013","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"2021113011023808900_B151","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1146\/annurev-physiol-021909-135725","article-title":"The physiological significance of the cardiotonic steroid\/ouabain-binding site of the Na,K-ATPase","volume":"72","author":"Lingrel","year":"2010","journal-title":"Annu. Rev. Physiol."},{"key":"2021113011023808900_B152","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/j.1749-6632.2003.tb07234.x","article-title":"Molecular mechanisms of Na\/K-ATPase-mediated signal transduction","volume":"986","author":"Xie","year":"2003","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"2021113011023808900_B153","doi-asserted-by":"publisher","first-page":"C491","DOI":"10.1152\/ajpcell.00359.2015","article-title":"Na+, K+-ATPase, a new class of plasma membrane receptors","volume":"310","author":"Aperia","year":"2016","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"2021113011023808900_B154","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1161\/01.HYP.0000252409.36927.05","article-title":"Marinobufagenin stimulates fibroblast collagen production and causes fibrosis in experimental uremic cardiomyopathy","volume":"49","author":"Elkareh","year":"2007","journal-title":"Hypertension"},{"key":"2021113011023808900_B155","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.coph.2016.01.009","article-title":"The physiological and clinical importance of sodium potassium ATPase in cardiovascular diseases","volume":"27","author":"Yan","year":"2016","journal-title":"Curr. Opin. Pharmacol."},{"key":"2021113011023808900_B156","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/j.1472-8206.2008.00620.x","article-title":"Na+\/K+-ATPase-mediated signal transduction and Na+\/K+-ATPase regulation","volume":"22","author":"Zhang","year":"2008","journal-title":"Fundamental Clin. Pharmacol."},{"key":"2021113011023808900_B157","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.placenta.2014.07.014","article-title":"Cardiotonic steroids induce anti-angiogenic and anti-proliferative profiles in first trimester extravillous cytotrophoblast cells","volume":"35","author":"Ehrig","year":"2014","journal-title":"Placenta"},{"key":"2021113011023808900_B158","doi-asserted-by":"publisher","DOI":"10.1096\/fj.14-252684","article-title":"Ouabain inhibits placental sFlt1 production by repressing HSP27-dependent HIF-1+\u00a6 pathway","author":"Rana","year":"2014","journal-title":"FASEB J."},{"key":"2021113011023808900_B159","doi-asserted-by":"publisher","first-page":"F1009","DOI":"10.1152\/ajprenal.00257.2015","article-title":"Increased urinary levels of podocyte glycoproteins, matrix metallopeptidases, inflammatory cytokines, and kidney injury biomarkers in women with preeclampsia","volume":"309","author":"Wang","year":"2015","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"2021113011023808900_B160","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.semnephrol.2004.07.008","article-title":"The renal response to preeclampsia","volume":"24","author":"Moran","year":"2004","journal-title":"Semin. Nephrol."},{"key":"2021113011023808900_B161","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1053\/j.ackd.2013.01.012","article-title":"Renal physiology of pregnancy","volume":"20","author":"Cheung","year":"2013","journal-title":"Adv. Chronic Kidney Dis."},{"key":"2021113011023808900_B162","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.2741\/2244","article-title":"Renal function during normal pregnancy and preeclampsia","volume":"12","author":"Jeyabalan","year":"2007","journal-title":"Front. Biosci."},{"key":"2021113011023808900_B163","doi-asserted-by":"publisher","first-page":"F1121","DOI":"10.1152\/ajprenal.00042.2014","article-title":"The renal circulation in normal pregnancy and preeclampsia: is there a place for relaxin?","volume":"306","author":"Conrad","year":"2014","journal-title":"Am. J. Physiol. Renal Physiology"},{"key":"2021113011023808900_B164","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1111\/j.1523-1755.2005.00189.x","article-title":"The kidney in preeclampsia","volume":"67","author":"Lafayette","year":"2005","journal-title":"Kidney Int."},{"key":"2021113011023808900_B165","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1681\/ASN.2007020255","article-title":"The glomerular injury of preeclampsia","volume":"18","author":"Stillman","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"2021113011023808900_B166","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/ki.2014.17","article-title":"Advances in the pathophysiology of pre-eclampsia and related podocyte injury","volume":"86","author":"Craici","year":"2014","journal-title":"Kidney Int."},{"key":"2021113011023808900_B167","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1053\/j.ackd.2013.01.013","article-title":"Preeclampsia: a \u201cnephrocentric\u201d view","volume":"20","author":"August","year":"2013","journal-title":"Adv. Chronic Kidney Dis."},{"key":"2021113011023808900_B168","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.ejca.2009.11.001","article-title":"VEGF signalling inhibition-induced proteinuria: mechanisms, significance and management","volume":"46","author":"Izzedine","year":"2010","journal-title":"Eur. J. Cancer"},{"key":"2021113011023808900_B169","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1161\/HYPERTENSIONAHA.116.07618","article-title":"Mechanisms of hypertension and renal injury during vascular endothelial growth factor signaling inhibition","volume":"68","author":"van den Meiracker","year":"2016","journal-title":"Hypertension"},{"key":"2021113011023808900_B170","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.amjmed.2008.11.025","article-title":"Renal effects of anti-angiogenesis therapy: update for the internist","volume":"122","author":"Gurevich","year":"2009","journal-title":"Am. J. Med."},{"key":"2021113011023808900_B171","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.ajog.2007.02.021","article-title":"Expectant management of severe preeclampsia remote from term: patient selection, treatment, and delivery indications","volume":"196","author":"Sibai","year":"2007","journal-title":"Am. J. Obstet. Gynecol."},{"key":"2021113011023808900_B172","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1056\/NEJMoa0706790","article-title":"Preeclampsia and the risk of end-stage renal disease","volume":"359","author":"Vikse","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"2021113011023808900_B173","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1161\/HYPERTENSIONAHA.116.08121","article-title":"Association of pregnancy complications and characteristics with future risk of elevated blood pressure","volume":"69","author":"Parikh","year":"2017","journal-title":"Hypertension"},{"key":"2021113011023808900_B174","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/S1701-2163(15)30383-2","article-title":"The Pulmonary Edema Preeclampsia Evaluation (PEPE) Study","volume":"36","author":"Gandhi","year":"2014","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"2021113011023808900_B175","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/0002-9378(87)90135-9","article-title":"Pulmonary edema in severe preeclampsia-eclampsia: analysis of thirty-seven consecutive cases","volume":"156","author":"Sibai","year":"1987","journal-title":"Am. J. Obstet. Gynecol."},{"key":"2021113011023808900_B176","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1053\/j.semperi.2009.02.008","article-title":"Cardiopulmonary complications of pre-eclampsia","volume":"33","author":"Bauer","year":"2009","journal-title":"Semin. Perinatol."},{"key":"2021113011023808900_B177","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ajog.2011.07.017","article-title":"Evaluation and management of severe preeclampsia before 34 weeks\u2019 gestation","volume":"205","author":"Sibai","year":"2011","journal-title":"Am. J. Obstet. Gynecol."},{"key":"2021113011023808900_B178","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1053\/j.semperi.2011.05.010","article-title":"Management of late preterm and early-term pregnancies complicated by mild gestational hypertension\/pre-eclampsia","volume":"35","author":"Sibai","year":"2011","journal-title":"Semin. Perinatol."},{"key":"2021113011023808900_B179","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1080\/10641950802601252","article-title":"Expectant management of severe preeclampsia remote from term: a structured systematic review","volume":"28","author":"Magee","year":"2009","journal-title":"Hypertens. Pregnancy"},{"key":"2021113011023808900_B180","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.ejogrb.2005.11.011","article-title":"Maternal and perinatal outcome of preeclampsia with an onset before 24 weeks\u2019 gestation. Audit in a tertiary referral center","volume":"128","author":"Gaugler-Senden","year":"2006","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"2021113011023808900_B181","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1055\/s-0029-1214243","article-title":"Expectant management of severe preeclampsia at 270\/7 to 336\/7 weeks\u2019 gestation: maternal and perinatal outcomes according to gestational age by weeks at onset of expectant management","volume":"26","author":"Bombrys","year":"2009","journal-title":"Am. J. Perinatol."},{"key":"2021113011023808900_B182","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1161\/HYPERTENSIONAHA.107.107607","article-title":"Placental origins of preeclampsia: challenging the current hypothesis","volume":"51","author":"Huppertz","year":"2008","journal-title":"Hypertension"},{"key":"2021113011023808900_B183","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1081\/PRG-120021060","article-title":"Subclassification of preeclampsia","volume":"22","author":"von Dadelszen","year":"2003","journal-title":"Hypertens. Pregnancy"},{"key":"2021113011023808900_B184","first-page":"124","article-title":"Maternal Morbidity Associated With Early-Onset and Late-Onset Preeclampsia","author":"Lisonkova","year":"2014","journal-title":"Obstet. Gynecol."},{"key":"2021113011023808900_B185","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3109\/10641950902972140","article-title":"Acute pulmonary oedema as a complication of hypertension during pregnancy","volume":"30","author":"Thornton","year":"2011","journal-title":"Hypertens. Pregnancy"},{"key":"2021113011023808900_B186","first-page":"511","article-title":"Acute pulmonary edema in pregnancy","volume":"101","author":"Sciscione","year":"2003","journal-title":"Obstet. Gynecol."},{"key":"2021113011023808900_B187","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1111\/j.1365-2044.2012.07055.x","article-title":"Acute pulmonary oedema in pregnant women","volume":"67","author":"Dennis","year":"2012","journal-title":"Anaesthesia"},{"key":"2021113011023808900_B188","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1111\/j.1471-0528.2005.00687.x","article-title":"A randomised controlled trial comparing two temporising management strategies, one with and one without plasma volume expansion, for severe and early onset pre-eclampsia","volume":"112","author":"Ganzevoort","year":"2005","journal-title":"BJOG"},{"key":"2021113011023808900_B189","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.ejogrb.2006.01.003","article-title":"Early pre-eclampsia: what proportion of women qualify for expectant management and if not, why not?","volume":"128","author":"Hall","year":"2006","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"2021113011023808900_B190","doi-asserted-by":"publisher","first-page":"2788","DOI":"10.1056\/NEJMcp052699","article-title":"Clinical practice. Acute pulmonary edema","volume":"353","author":"Ware","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"2021113011023808900_B191","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/S0002-9378(85)80222-2","article-title":"Hemodynamic observations in severe preeclampsia complicated by pulmonary edema","volume":"152","author":"Benedetti","year":"1985","journal-title":"Am. J. Obstet. Gynecol."},{"key":"2021113011023808900_B192","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1080\/14767058.2016.1262842","article-title":"Maternal cardiac haemodynamics in severe pre-eclampsia complicated by acute pulmonary oedema: A review","volume":"30","author":"Bhorat","year":"2016","journal-title":"J. Mater. Fetal Neonatal Med."},{"key":"2021113011023808900_B193","first-page":"227","article-title":"Pulmonary edema associated with pregnancy: echocardiographic insights and implications for treatment","volume":"81","author":"Mabie","year":"1993","journal-title":"Obstet. Gynecol."},{"key":"2021113011023808900_B194","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/0002-9378(88)90017-8","article-title":"Hemodynamic profile of severe pregnancy-induced hypertension","volume":"158","author":"Cotton","year":"1988","journal-title":"Am. J. Obstet. Gynecol."},{"key":"2021113011023808900_B195","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1016\/0002-9378(89)90901-0","article-title":"The central hemodynamics of severe preeclampsia","volume":"161","author":"Mabie","year":"1989","journal-title":"Am. J. Obstet. Gynecol."},{"key":"2021113011023808900_B196","doi-asserted-by":"publisher","first-page":"454","DOI":"10.3109\/10641955.2012.697951","article-title":"Severe myocardial impairment and chamber dysfunction in preterm preeclampsia","volume":"31","author":"Melchiorre","year":"2012","journal-title":"Hypertens. Pregnancy"},{"key":"2021113011023808900_B197","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1161\/CIRCULATIONAHA.113.003664","article-title":"Cardiovascular implications in preeclampsia: an overview","volume":"130","author":"Melchiorre","year":"2014","journal-title":"Circulation"},{"key":"2021113011023808900_B198","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ijoa.2012.11.001","article-title":"Utility of B-type natriuretic peptides in preeclampsia: a systematic review","volume":"22","author":"Afshani","year":"2013","journal-title":"Int. J. Obstet. Anesth."},{"key":"2021113011023808900_B199","doi-asserted-by":"publisher","first-page":"130","DOI":"10.5830\/CVJA-2013-023","article-title":"Cardiovascular haemodynamics in pre-eclampsia using brain naturetic peptide and tissue Doppler studies","volume":"24","author":"Fayers","year":"2013","journal-title":"Cardiovasc. J. Afr."},{"key":"2021113011023808900_B200","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ejogrb.2010.06.011","article-title":"Amino-terminal pro-brain natriuretic peptide (NT-proBNP) is a biomarker of cardiac filling pressures in pre-eclampsia","volume":"153","author":"Speksnijder","year":"2010","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"2021113011023808900_B201","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1042\/cs0770599","article-title":"Capillary permeability and extracellular fluid volumes in pregnancy-induced hypertension","volume":"77","author":"Brown","year":"1989","journal-title":"Clin. Sci. (Lond.)"},{"key":"2021113011023808900_B202","first-page":"163","article-title":"Evans Blue disappearance rate in normal and pre-eclamptic pregnancy","volume":"2","author":"Campbell","year":"1983","journal-title":"Clin. Exp. Hypertens. B"},{"key":"2021113011023808900_B203","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1159\/000193220","article-title":"Vascular Leak in a Rat Model of Preeclampsia","volume":"30","author":"Uddin","year":"2009","journal-title":"Am. J. Nephrol."},{"key":"2021113011023808900_B204","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1067\/mob.2002.119638","article-title":"Endothelial junctional protein redistribution and increased monolayer permeability in human umbilical vein endothelial cells isolated during preeclampsia","volume":"186","author":"Wang","year":"2002","journal-title":"Am. J. Obstet. Gynecol."},{"key":"2021113011023808900_B205","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.ajog.2003.09.049","article-title":"Evidence of endothelial dysfunction in preeclampsia: decreased endothelial nitric oxide synthase expression is associated with increased cell permeability in endothelial cells from preeclampsia","volume":"190","author":"Wang","year":"2004","journal-title":"Am. J. Obstet. Gynecol."},{"key":"2021113011023808900_B206","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1081\/PRG-120017008","article-title":"Increased endothelial monolayer permeability is induced by serum from women with preeclampsia but not by serum from women with normal pregnancy or that are not pregnant","volume":"22","author":"Zhang","year":"2003","journal-title":"Hypertens. Pregnancy"},{"key":"2021113011023808900_B207","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1161\/HYPERTENSIONAHA.116.06421","article-title":"Angiogenic Factors in Preeclampsia: From Diagnosis to Therapy","volume":"67","author":"Karumanchi","year":"2016","journal-title":"Hypertension"},{"key":"2021113011023808900_B208","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1161\/CIRCULATIONAHA.109.853127","article-title":"Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease","volume":"123","author":"Powe","year":"2011","journal-title":"Circulation"},{"key":"2021113011023808900_B209","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/0002-9378(89)90665-0","article-title":"Preeclampsia: an endothelial cell disorder","volume":"161","author":"Roberts","year":"1989","journal-title":"Am. J. Obstet. Gynecol."},{"key":"2021113011023808900_B210","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/nm1429","article-title":"Soluble endoglin contributes to the pathogenesis of preeclampsia","volume":"12","author":"Venkatesha","year":"2006","journal-title":"Nat. Med."},{"key":"2021113011023808900_B211","doi-asserted-by":"publisher","first-page":"R918","DOI":"10.1152\/ajpregu.00499.2013","article-title":"Marinobufagenin regulates permeability and gene expression of brain endothelial cells","volume":"306","author":"Ing","year":"2014","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"2021113011023808900_B212","doi-asserted-by":"publisher","first-page":"R1726","DOI":"10.1152\/ajpregu.90963.2008","article-title":"Marinobufagenin causes endothelial cell monolayer hyperpermeability by altering apoptotic signaling","volume":"296","author":"Uddin","year":"2009","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"2021113011023808900_B213","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/j.1600-0897.2011.01055.x","article-title":"Digoxin Immune Fab Protects Endothelial Cells from Ouabain-Induced Barrier Injury","volume":"67","author":"Wang","year":"2012","journal-title":"Am. J. Reprod. Immunol."},{"key":"2021113011023808900_B214","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1172\/JCI60331","article-title":"The acute respiratory distress syndrome","volume":"122","author":"Matthay","year":"2012","journal-title":"J. Clin. Invest."},{"key":"2021113011023808900_B215","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1152\/physrev.00003.2002","article-title":"Lung epithelial fluid transport and the resolution of pulmonary edema","volume":"82","author":"Matthay","year":"2002","journal-title":"Physiol. Rev."},{"key":"2021113011023808900_B216","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1007\/s00134-007-0661-8","article-title":"Alveolar epithelium and Na,K-ATPase in acute lung injury","volume":"33","author":"Vadasz","year":"2007","journal-title":"Intensive Care Med."},{"key":"2021113011023808900_B217","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1111\/echo.13182","article-title":"Pulmonary Edema Assessed by Ultrasound: Impact in Cardiology and Intensive Care Practice","volume":"33","author":"Blanco","year":"2016","journal-title":"Echocardiography"},{"key":"2021113011023808900_B218","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1378\/chest.09-0001","article-title":"A-lines and B-lines: lung ultrasound as a bedside tool for predicting pulmonary artery occlusion pressure in the critically ill","volume":"136","author":"Lichtenstein","year":"2009","journal-title":"Chest"},{"key":"2021113011023808900_B219","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1476-7120-6-16","article-title":"Chest sonography: a useful tool to differentiate acute cardiogenic pulmonary edema from acute respiratory distress syndrome","volume":"6","author":"Copetti","year":"2008","journal-title":"Cardiovasc. Ultrasound"},{"key":"2021113011023808900_B220","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1177\/2048872614553166","article-title":"Role and importance of ultrasound lung comets in acute cardiac care","volume":"4","author":"Ricci","year":"2015","journal-title":"Eur. Heart J. Acute Cardiovasc. Care"},{"key":"2021113011023808900_B221","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/anae.12037","article-title":"Lung ultrasound-guided management of acute breathlessness during pregnancy","volume":"68","author":"Zieleskiewicz","year":"2013","journal-title":"Anaesthesia"},{"key":"2021113011023808900_B222","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1097\/ALN.0000000000000102","article-title":"Lung ultrasound predicts interstitial syndrome and hemodynamic profile in parturients with severe preeclampsia","volume":"120","author":"Zieleskiewicz","year":"2014","journal-title":"Anesthesiology"},{"key":"2021113011023808900_B223","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/uog.17331","article-title":"Lung and cardiac ultrasound for hemodynamic monitoring of patients with severe pre-eclampsia","volume":"49","author":"Ambrozic","year":"2017","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"2021113011023808900_B224","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.jash.2008.10.001","article-title":"Hypertension in pregnancy","volume":"2","author":"Lindheimer","year":"2008","journal-title":"J. Am. Soc. Hypertension"},{"key":"2021113011023808900_B225","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1161\/01.HYP.17.6.1072","article-title":"Central hemodynamic observations in untreated preeclamptic patients","volume":"17","author":"Visser","year":"1991","journal-title":"Hypertension"},{"key":"2021113011023808900_B226","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1177\/1753944715624853","article-title":"The emerging role of endothelin-1 in the pathogenesis of pre-eclampsia","volume":"10","author":"Saleh","year":"2016","journal-title":"Therapeutic Adv. Cardiovasc. Dis."},{"key":"2021113011023808900_B227","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.bcp.2015.04.012","article-title":"Bioactive factors in uteroplacental and systemic circulation link placental ischemia to generalized vascular dysfunction in hypertensive pregnancy and preeclampsia","volume":"95","author":"Shah","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"2021113011023808900_B228","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/j.1365-2362.2004.01350.x","article-title":"Pregnancy-induced sympathetic overactivity: a precursor of preeclampsia","volume":"34","author":"Fischer","year":"2004","journal-title":"Eur. J. Clin. Invest."},{"key":"2021113011023808900_B229","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1056\/NEJM199611143352002","article-title":"Preeclampsia \u2013 a state of sympathetic overactivity","volume":"335","author":"Schobel","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"2021113011023808900_B230","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1042\/CS20160108","article-title":"Preeclampsia and the brain: neural control of cardiovascular changes during pregnancy and neurological outcomes of preeclampsia","volume":"130","author":"Logue","year":"2016","journal-title":"Clin. Sci. (Lond.)"},{"key":"2021113011023808900_B231","doi-asserted-by":"publisher","first-page":"H541","DOI":"10.1152\/ajpheart.01113.2007","article-title":"Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction","volume":"294","author":"Gilbert","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"2021113011023808900_B232","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1042\/CS20171036","article-title":"The influence of prenatal exercise and pre-eclampsia on maternal vascular function","volume":"131","author":"Skow","year":"2017","journal-title":"Clin. Sci. (Lond.)"},{"key":"2021113011023808900_B233","doi-asserted-by":"publisher","first-page":"H1827","DOI":"10.1152\/ajpheart.00010.2016","article-title":"Impaired sodium-dependent adaptation of arterial stiffness in formerly preeclamptic women: the RETAP-vascular study","volume":"310","author":"van der Graaf","year":"2016","journal-title":"Am. J. Physiol. - Heart Circ. Physiol."},{"key":"2021113011023808900_B234","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1097\/GRF.0000000000000254","article-title":"Controversies regarding diagnosis and treatment of severe hypertension in pregnancy","volume":"60","author":"Barton","year":"2017","journal-title":"Clin. Obstet. Gynecol."},{"key":"2021113011023808900_B235","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.jemermed.2008.04.039","article-title":"Postpartum preeclampsia occurring after resolution of antepartum preeclampsia","volume":"38","author":"Andrus","year":"2010","journal-title":"J. Emerg. Med."},{"key":"2021113011023808900_B236","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1016\/j.ajog.2004.02.037","article-title":"Delayed postpartum preeclampsia: an experience of 151 cases","volume":"190","author":"Matthys","year":"2004","journal-title":"Am. J. Obstet. Gynecol."},{"key":"2021113011023808900_B237","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.jemermed.2008.02.056","article-title":"Postpartum preeclampsia: emergency department presentation and management","volume":"40","author":"Yancey","year":"2011","journal-title":"J. Emerg. Med."},{"key":"2021113011023808900_B238","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/jp.2015.209","article-title":"Clinical factors associated with readmission for postpartum hypertension in women with pregnancy-related hypertension: a nested case control study","volume":"36","author":"Hirshberg","year":"2016","journal-title":"J. Perinatol."},{"key":"2021113011023808900_B239","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1097\/AOG.0b013e3181c14e3e","article-title":"Resolution of hypertension and proteinuria after preeclampsia","volume":"114","author":"Berks","year":"2009","journal-title":"Obstet. Gynecol."},{"key":"2021113011023808900_B240","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1093\/clinchem\/40.8.1595","article-title":"Sensitive assay for sodium pump inhibition","volume":"40","author":"Tao","year":"1994","journal-title":"Clin. Chem."},{"key":"2021113011023808900_B241","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1542\/peds.107.1.e1","article-title":"Very low birth weight outcomes of the National Institute of Child health and human development neonatal research network, January 1995 through December 1996. NICHD Neonatal Research Network","volume":"107","author":"Lemons","year":"2001","journal-title":"Pediatrics"},{"key":"2021113011023808900_B242","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3171\/2011.12.PEDS11136","article-title":"Neonatal posthemorrhagic hydrocephalus from prematurity: pathophysiology and current treatment concepts","volume":"9","author":"Robinson","year":"2012","journal-title":"J. Neurosurg. Pediatr."},{"key":"2021113011023808900_B243","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/jp.2016.38","article-title":"Impact of antenatal steroids on intraventricular hemorrhage in very-low-birth weight infants","volume":"36","author":"Wei","year":"2016","journal-title":"J. Perinatol."},{"key":"2021113011023808900_B244","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1001\/jamapediatrics.2014.3040","article-title":"The distribution of clinical phenotypes of preterm birth syndrome: implications for prevention","volume":"169","author":"Barros","year":"2015","journal-title":"JAMA Pediatr"},{"key":"2021113011023808900_B245","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1016\/0002-9378(95)91412-9","article-title":"Neonatal outcome after preterm delivery for preeclampsia","volume":"172","author":"Friedman","year":"1995","journal-title":"Am. J. Obstet. Gynecol."},{"key":"2021113011023808900_B246","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1055\/s-0029-1234036","article-title":"Do neonatal outcomes differ depending on the cause of preterm birth? A comparison between spontaneous birth and iatrogenic delivery for preeclampsia","volume":"27","author":"Bastek","year":"2010","journal-title":"Am. J. Perinatol."},{"key":"2021113011023808900_B247","doi-asserted-by":"publisher","first-page":"e590","DOI":"10.1542\/peds.111.5.e590","article-title":"Risk factors for intraventricular hemorrhage in very low birth weight premature infants: a retrospective case-control study","volume":"111","author":"Linder","year":"2003","journal-title":"Pediatrics"},{"key":"2021113011023808900_B248","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1203\/00006450-200111000-00003","article-title":"Neurobiology of periventricular leukomalacia in the premature infant","volume":"50","author":"Volpe","year":"2001","journal-title":"Pediatr. Res."},{"key":"2021113011023808900_B249","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0895-7061(95)00260-X","article-title":"Reversal of sodium pump inhibitor induced vascular smooth muscle contraction with digibind. Stoichiometry and its implications","volume":"9","author":"Krep","year":"1996","journal-title":"Am. J. Hypertens"},{"key":"2021113011023808900_B250","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.jped.2014.09.008","article-title":"Peri-intraventricular hemorrhage and oxidative and inflammatory stress markers in very-low birth weight newborns","volume":"91","author":"Caldas","year":"2015","journal-title":"J. Pediatr."},{"key":"2021113011023808900_B251","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1093\/oxfordjournals.aje.a116619","article-title":"Incidence and timing of germinal matrix\/intraventricular hemorrhage in low birth weight infants","volume":"137","author":"Paneth","year":"1993","journal-title":"Am. J. Epidemiol."},{"key":"2021113011023808900_B252","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1056\/NEJM198404263101707","article-title":"Necrotizing enterocolitis","volume":"310","author":"Kliegman","year":"1984","journal-title":"N. Engl. J. Med."},{"key":"2021113011023808900_B253","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1056\/NEJM199206253262604","article-title":"The use of digoxin-specific Fab fragments for severe digitalis intoxication in children","volume":"326","author":"Woolf","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"2021113011023808900_B254","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1093\/ajh\/hpt233","article-title":"Examination of intrarenal resistance indices indicate the involvement of renal pathology as a significant diagnostic classifier of preeclampsia","volume":"27","author":"Bahser","year":"2014","journal-title":"Am. J. Hypertens."},{"key":"2021113011023808900_B255","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1080\/14767058.2016.1234785","article-title":"E5. Lung ultrasound and echocardiography for peripartum haemodynamic monitoring of patients with severe preeclampsia","volume":"29","author":"Ambrozic","year":"2016","journal-title":"J. Mater. Fetal Neonatal Med."},{"key":"2021113011023808900_B256","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1016\/0024-3205(91)90309-Y","article-title":"Digoxin-like immunoreactivity: is it still worth measuring?","volume":"49","author":"Goto","year":"1991","journal-title":"Life Sci."},{"key":"2021113011023808900_B257","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/0306-9877(87)90053-3","article-title":"Will treatment with digoxin antibody benefit pregnant patients with toxemia and elevated digoxin like factor?","volume":"24","author":"Goodlin","year":"1987","journal-title":"Med. Hypotheses"}],"container-title":["Clinical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/132\/12\/1215\/449924\/cs-2017-1499.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/132\/12\/1215\/449924\/cs-2017-1499.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T16:51:47Z","timestamp":1720371107000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/clinsci\/article\/132\/12\/1215\/72095\/Role-of-endogenous-digitalis-like-factors-in-the"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,21]]},"references-count":257,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,6,29]]}},"URL":"https:\/\/doi.org\/10.1042\/cs20171499","relation":{},"ISSN":["0143-5221","1470-8736"],"issn-type":[{"value":"0143-5221","type":"print"},{"value":"1470-8736","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,21]]}}}